Image via Wikipedia
The subject of producing artificial blood from stem cells has become a hot topic in Italy. “Italy is close to reaching the same objective announced by British researchers, on a similar timeframe,” therefore possibly in three years, “but using adult stem cells. Certainly, it is one thing to say that in three years we will begin the experimental phase, it’s another thing to speak about industrial production. It needs to be specified that the procedure to produce artificial blood is very expensive. Therefore this would be a complementary solution, which will not replace
Image by Getty Images via Daylife
Here’s a story about life that begins on the No. 2 toe — the one next to the big toe — on the right foot of Jasmina Anema. In early January, a red blip, the size of a bug bite, appeared. It got itchy, and she told her mom, Thea Anema.
“It looked like nothing,” the mother said. Then the foot started to swell. On the morning of Jan. 20, on their way to Jasmina’s kindergarten at Public School 141 in Greenwich Village, they stopped at the pediatrician’s office.
Her abdomen was swollen; a test found
In a ray of hope for millions of leukaemia patients, American scientists have claimed to have developed a technique which multiplies the small number of stem cells in the donor blood, making it much more potent for the treatment of the fatal disease.
It also eliminates the need for a matching donor, whose bone marrow is usually transplanted to the patient, according to a study which appeared in the journal Nature Medicine. Traditionally, there was always a risk that the patient’s body may reject the new cells from a donor.
Image by steve p2008 via Flickr
After making news on several occasions, scientists may have made a definitive breakthrough, with the first possible transfusion using blood obtained from embryonic stem cells possibly coming within the next three years. The transfusion would be done with type O blood, which can be donated to any patient, and would be obtained by researchers using excess embryos from assisted fertilization. The project, which will be led by Marc Turner of Edinburgh University, will also receive contributions from the Transfusion and Transplant Service of the British National Health Service, as well as the